P. F. Langley
- Pharmacology top 5%
- Pharmacology top 5%
- Psychiatry and Mental health top 10%
- Cellular and Molecular Neuroscience
- Molecular Biology
- Co-authors
- R. E. HaddockBarry D. ZussmanG. MellowsW. H. GrebC M KayeD. M. BrownMargaret JohnsonDavid R. Nelson
- Topics
- Antibiotics Pharmacokinetics and Efficacy (5 papers)Drug Transport and Resistance Mechanisms (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)
- Cited by
- PharmacologyBiological Psychiatry
- Journals
- The American Journal of MedicineBiochemical PharmacologyToxicology and Applied Pharmacology
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
P. F. Langley
14 papers receiving 381 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 174
- Pharmacology 118
- Psychiatry and Mental health 92
- Cellular and Molecular Neuroscience 67
- Molecular Biology 61
Countries citing papers authored by P. F. Langley
This map shows the geographic impact of P. F. Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. F. Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. F. Langley more than expected).
Fields of papers citing papers by P. F. Langley
This network shows the impact of papers produced by P. F. Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. F. Langley. The network helps show where P. F. Langley may publish in the future.
Co-authorship network of co-authors of P. F. Langley
This figure shows the co-authorship network connecting the top 25 collaborators of P. F. Langley. A scholar is included among the top collaborators of P. F. Langley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. F. Langley. P. F. Langley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 79 | |
| 2 | 208 | |
| 3 | 16 | |
| 4 | 12 | |
| 5 | 10 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 13 | |
| 9 | 27 | |
| 10 | 39 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 2 | |
| 14 | 5 |
About P. F. Langley
P. F. Langley is a scholar working on Molecular Medicine, Process Chemistry and Technology and Pharmacology, having authored 14 papers that have together received 429 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Pharmacology (118 citations), Pharmacology (174 citations) and Biological Psychiatry (19 citations). P. F. Langley has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include R. E. Haddock, Barry D. Zussman, G. Mellows, W. H. Greb, C M Kaye, D. M. Brown, Margaret Johnson, David R. Nelson, D.R. Thomas and Duane R. Smith. Their work appears in journals such as The American Journal of Medicine, Biochemical Pharmacology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.